American Society of Hirudotherapy

Meralgia Paresthetica (Investigational Adjunct)

Investigational adjunct for meralgia paresthetica; weight loss, loosening of constrictive clothing, and selective nerve block remain first-line.

Tier C — InvestigationalInvestigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Last Updated: November 12, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
Not FDA-cleared for meralgia paresthetica. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
What evidence exists?
Tier C (investigational). No controlled clinical study of leech therapy for meralgia paresthetica was identified, so its effect is unknown. A Russian medical book retells a report from clinical practice about Roth–Bernhardt disease, which by description appears to be the same condition, without patient numbers or a comparison group (see “What the books describe” below). Most meralgia paresthetica resolves spontaneously over weeks to months. Evidence-based first-line care is loosening of tight belts, waistbands, and corsets; weight loss; NSAIDs for short-term symptom relief; treatment of pregnancy-related cases conservatively (most resolve postpartum); and lateral femoral cutaneous nerve block (both diagnostic and therapeutic) for refractory cases. Persistent severe symptoms can be managed with pulsed radiofrequency or, rarely, surgical neurolysis.
Main risks
  • Bleeding from the bite site for 6 to 24 hours after detachment
  • Bruising over the lateral hip for 5 to 10 days
  • Local skin or, rarely, Aeromonas hydrophila infection
  • Allergic reaction to leech saliva (uncommon)
  • Worsening burning, dysesthesia, or numbness from disturbing an irritated nerve
  • Delay of weight management, garment adjustment, or nerve block - the evidence-based interventions
  • Risk if placed too close to the inguinal ligament or femoral triangle (femoral vessels, femoral nerve)
Who should not consider this
  • Patients with suspected lumbar radiculopathy (L2-L3) - this requires MRI and a different treatment plan
  • Patients with diabetes and undiagnosed diabetic mononeuropathy - workup before procedural intervention
  • Pregnant patients whose meralgia is pregnancy-related (typically self-resolves postpartum)
  • Patients who have not tried garment adjustment, weight management, and at least 8 weeks of conservative care
  • Patients on anticoagulants, with hemophilia, or with anemia
  • Patients with active dermatitis or broken skin over the lateral hip
What to ask your clinician
  • Have we ruled out lumbar radiculopathy (L2-L3), diabetic mononeuropathy, or femoral neuropathy?
  • Have I addressed weight, tight clothing, belts, and posture - the main drivers?
  • Have I tried NSAIDs and given the condition time to self-resolve (3 to 6 months in most cases)?
  • Has a lateral femoral cutaneous nerve block been offered, and what is its evidence?
  • Where exactly will the leech be placed - confirm it is lateral to the ASIS, NEVER near the inguinal ligament or femoral triangle?
  • What is the practitioner's plan if symptoms do not improve or worsen after one session?
  • What is the Aeromonas-prevention protocol?
When to seek urgent care
  • Sudden severe groin or thigh pain with weakness or inability to flex the hip (possible femoral nerve injury)
  • Sudden loss of pulse in the leg, cold foot, or pallor (possible femoral artery injury)
  • Spreading redness, warmth, or pus at the bite site
  • Bleeding from the bite site lasting more than 24 hours
  • Fever above 38.0 C / 100.4 F or chills
  • Hives, facial or throat swelling, or breathing difficulty

What this does NOT mean

  • This is not FDA-cleared for meralgia paresthetica.
  • It does not address the underlying cause (obesity, tight clothing, pregnancy, prior surgery), which is the actual driver.
  • It does not replace nerve block, which is both diagnostic and therapeutic in refractory cases.
  • Most meralgia paresthetica self-resolves; the natural history confounds any apparent benefit.
  • No controlled clinical study of leech therapy for meralgia paresthetica was identified; a report retold in a Russian medical book (see “What the books describe” below) names no patient numbers or comparison group, so its benefit is unproven.

Clinical Profile

Category
Neurological
ICD-10
G57.10, G57.11, G57.12
Safety tier
Low

Evidence Summary

Meralgia paresthetica is lateral femoral cutaneous nerve entrapment producing numbness and burning in the anterolateral thigh, often related to obesity, tight belts or waistbands, pregnancy, or prior pelvic surgery. Evidence-based management includes loosening of constrictive garments, weight loss, NSAIDs, and lateral femoral cutaneous nerve block (diagnostic and therapeutic) for refractory cases. Most cases resolve spontaneously within months. No clinical study or case report of hirudotherapy for meralgia paresthetica was identified in PubMed, Europe PMC or Crossref as of October 2026; the Baskova and Isakhanyan 2004 monograph retells reports (Zhavoronkova 1995 and 1999) of patients with Roth–Bernhardt disease, which by its description matches meralgia paresthetica although the book does not use that name, and names no patient numbers or comparison group (see “What the books describe” below); otherwise any rationale is mechanistic only. The femoral neurovascular bundle and inguinal ligament require careful avoidance.

What the books describe

Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.

  • The word “meralgia” does not occur in either of the two books; Baskova and Isakhanyan write about Roth–Bernhardt disease (in the text, “Rota-Bern Garda”) and attribute the pain syndrome in it to injury of the lateral cutaneous nerve against the edge of the iliac bone; the book does not say that this is the same condition that this page calls meralgia — the comparison is made here from the description (lateral cutaneous nerve, outer surface of the thigh)[B1].
  • According to a report retold by the authors (Zhavoronkova, 1995; 1999), with the use of hirudotherapy the patients had disappearance of unpleasant sensations on the outer surface of the thigh and fewer pain attacks[B1].
  • How many patients there were, whether there was a comparison group and how long they were followed is not stated in this place in the book[B1].
  • Roth–Bernhardt disease is also named in the list of diseases for which, as Baskova and Isakhanyan write citing published information, treatment with leeches is recommended[B1].
  • Michalsen et al. do not write about Roth–Bernhardt disease or about meralgia[B3].
  • Among the contraindications, Baskova and Isakhanyan name hemophilia, hemorrhagic diatheses, anemia, low blood pressure, acute vascular insufficiency (shock, collapse, fainting), exhaustion (cachexia), concurrent use of anticoagulants and alcohol, and individual intolerance; they advise refraining when body temperature is high, call the question of pregnancy open, and regard prescribing leeches in large numbers, for long periods, without breaks or with short breaks as unjustified and impermissible[B1].
  • Flecken and Michalsen (Chapter 8) call hemophilia and the use of anticoagulants an absolute contraindication, write that aspirin and clopidogrel are not in themselves a contraindication (in which case fewer leeches are needed at the first session), and that in anemia and in pregnancy treatment involving blood loss is, as a rule, contraindicated; this is only part of the contraindications listed in the books[B3].

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Placement near inguinal ligament or femoral triangle
  • Diabetes without optimization (overlap with diabetic mononeuropathy)
  • Lumbar radiculopathy mimicking meralgia (workup first)

Related Conditions

References

  • [B1]

    Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]

    Москва: Монолит(2004)https://search.rsl.ru/ru/record/01007959553

    Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.

  • [B3]

    Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy

    Stuttgart — New York: Thieme(2007)https://books.google.com/books?vid=ISBN9781588905635

    ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.

The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.